Search for Clinical Trial Results
Monoclonal Gammopathy of Undetermined Significance - 25 Studies Found
Status | Study |
Completed |
Study Name: Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma Condition:
|
Completed |
Study Name: Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma Condition:
|
Completed |
Study Name: S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma Condition:
|
Completed |
Study Name: RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy Condition: Polyneuropathy Date: 2005-11-29 Interventions: Drug: Rituximab Rituximab |
Completed |
Study Name: Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis Condition:
Date: 2005-09-12 |
Terminated |
Study Name: Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma Condition:
Date: 2009-07-17 Interventions:
|
Withdrawn |
Study Name: Imaging Studies and the Development of Multiple Myeloma Condition:
Date: 2016-04-11 |
Terminated |
Study Name: Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) Condition:
|
Recruiting |
Study Name: Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource Condition:
|